In 1986 Ole Rafaelsen and William Bunney were instrumental in establiching a CINP programme supporting the attendance of young scientists at the XXVth CINP Congress in 1986. That programme was posthumously named the Rafaelsen Fellowship Award to honour Dr. Rafaelsen, who died in 1987.
CINP are pleased to announce the winners of the Rafaelsen Young Investigators Award at the CINP Thematic Meeting on Major Psychoses and Substance Abuse:
Ulrich Ettinger studied psychology at Goldsmiths College and neuroscience at the Institute of Psychiatry. He wrote his PhD on schizophrenia endophenotypes. In 2003 he moved to McGill University on a Richard H. Tomlinson Fellowship. In 2004 he returned to the Institute of Psychiatry to work as ESRC/MRC, Leverhulme, and NIHR fellow. Since January 2009 he heads a research group at the University of Munich. His main research interests are (1) molecular genetics of oculomotor, cognitive and neuroimaging phenotypes, (2) pharmacological studies of oculomotor, cognitive and neuroimaging variables with particular focus on the prediction of inter-individual response variability and (3) neural correlates of oculomotor control.
Leonora started work as a pharmacist practicing in hospital psychiatric pharmacy and community-based opiate dependence pharmacotherapy dispensing. Her PhD at Monash University built on these interests, investigating cannabis-based compounds in rodent behavioural models of schizophrenia symptoms. Following a postdoctoral position at the University of Sydney she returned to investigating cannabinoids in a genetic animal model of schizophrenia with Schizophrenia Research Institute and Prince of Wales Medical Research Institute. Future research aims are to investigate the role of cannabinoids in regulating brain development and to assess the impact of disruption of this regulation, in conjunction with other environmental and genetic risk factors, on adolescent and adult mental health.
Dr. Saddichha Sahoo is presently working as Senior Research Fellow in Clinical Research Division of the Emergency Management and Research Institute, Hyderabad, India. He completed his psychiatry residency training from Central Institute of Psychiatry (CIP), India and became a Member of Indian Psychiatric Society, International Society for Bipolar Disorders and the American College of Clinical Pharmacology.
His research area includes neuropsychopharmacology, Schizophrenia, bipolar disorders, addiction, stigma and community mental health. He is currently working on exploring the links between substance use and psychosis.
He has over 50 academic publications in international and national indexed journals and is on the review board of 10 international journals of psychiatry and public health. He has won various awards including Siddartha Memorial Award for Best Research Paper (2007), ISAD Travel Award in Affective Disorders (2008), Society of Biological Psychiatry (SOBP) Travel Award in Schizophrenia (2008), WFSBP Young Investigator Award in biological psychiatry (2008), WCTOH Scholarship in public health (2009) and recently CINP Rafaelsen Young Investigators travel award (2009). He is also the recipient of an IBRO Fellowship for training in Functional genomics and presenting at the Hong Kong Congress of Neuroscience 2009 held at Hong Kong.
Christian Schubart (1976) was born in Haarlem, The Netherlands and was raised in Spain and Germany. He received his European Baccalaureate from the European School in Bergen, The Netherlands (Cum Laude) in 1995. After a year of volunteer work, he attended the University of Amsterdam to become a medical doctor. As a medical student he worked in the Oxford-KEMRI-Wellcome Trust laboratory in Kenya investigating the role of neurotropic viruses in the clinical presentation of cerebral malaria. Shortly after graduating from medical school, Chris started his clinical residencies in psychiatry and is now parallelly working on his doctorate in psychiatric genetics under the supervision of Professor René Kahn. He is involved in several studies focussing on the role of Gene Environment interplay in the aetiology of psychotic disorders. The aim of his current work is to identify genetic variation that underlies the interaction between genes, cannabis use and the risk to develop schizophrenia. Chris is a member of the Scientific Advisory Board of the Netherlands Society of Psychiatry and of the Board of Inspection of Psychiatric Residencies. He has been a member of the organizing committees of different international meetings in the field of psychiatry and tropical medicine and has published in several internationally peer reviewed journals.